From GlobeNewswire: 2024-05-02 08:00:00

Recursion (NASDAQ: RXRX) will report its first quarter 2024 financial results on May 9, 2024, following the close of the financial markets. A quarterly L(earnings) Call will be hosted at 5:00 pm Eastern Time / 3:00 pm Mountain Time, with open opportunities for the public to ask questions via online platforms including X, LinkedIn, and YouTube.

As a clinical stage TechBio company, Recursion is pioneering drug discovery by decoding biology and leveraging machine-learning algorithms across diverse technologies. With one of the world’s largest biological and chemical datasets, Recursion conducts millions of experiments weekly to advance the future of medicine. Headquartered in Salt Lake City, Recursion is a founding member of BioHive, with additional offices in Toronto, Montréal, and the San Francisco Bay Area.

This information contains forward-looking statements about early and late stage discovery, collaboration activities, and business and financial plans under the Securities Litigation Reform Act of 1995. Risks and uncertainties may impact actual results, including challenges in pharmaceutical research and development, obtaining regulatory approval, cybersecurity threats, and macroeconomic issues. Recursion does not undertake to correct or update forward-looking statements unless required by law.



Read more at GlobeNewswire:: Recursion to Report First Quarter 2024 Business Updates and